Pharmafile Logo
Pharmafocus logo
Advanced Search

Update on the planned consolidation of UK medicines legislation

November 21, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Earlier this year we reported on progress in the consolidation of the UK medicines legislation and that the Medicines and …

News
Press release

EMA accepts submission of Pfizer’s new arthritis drug

November 21, 2011
Research and Development, Sales and Marketing EMA, Pfizer, tofacitinib

The European Medicines Agency has accepted Pfizer’s arthritis drug tofacitinib for review.Tofacitinib is a novel, oral JAK inhibitor being studied …

News
Sweden pic

What does it take to make integrated care work?

November 21, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Feature

Andreas Pott appointed deputy executive director of European Medicines Agency

November 21, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Europe

The European Medicines Agency’s new executive director Guido Rasi has appointed Andreas Pott as deputy executive director. Pott’s appointment follows …

Appointment
Avastin picture

FDA pulls Roche’s Avastin for breast cancer

November 21, 2011
Research and Development, Sales and Marketing FDA, Roche, avastin

The FDA has pulled Avastin’s breast cancer licence in the US after the drug failed to prove its safety and …

News
dipankar_bhattacharjee_teva

Dipankar Bhattacharjee becomes vice president of Teva Northern Europe

November 21, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva

Dipankar Bhattacharjee has been promoted to vice president of UK and Teva Northern Europe. Teva said that as part of …

Appointment

Manufacturing drives growth at Wuxi Pharmatech

November 21, 2011
Manufacturing and Production WuXi PharmaTech

Chinese outsourcing services specialist WuXi Pharmatech reported a 24% increase in third-quarter sales to $104 million thanks to a robust …

News

Novartis workers stage flash strike over job cuts

November 21, 2011
Manufacturing and Production Novartis, Switzerland, job cuts

Workers at Novartis’ Nyon facility in Switzerland carried out a strike to protest the closure of the plant, but called …

News

AstraZeneca’s thyroid cancer drug gets CHMP nod

November 21, 2011
Sales and Marketing AstraZeneca, CHMP, Caprelsa, vandetanib

AstraZeneca’s thyroid cancer pill Caprelsa has taken a step closer to European approval after being recommended by the CHMP.Caprelsa (vandetanib) …

News
rampd-charnwood

AstraZeneca’s UK research centre prepares to close

November 18, 2011
Research and Development AstraZeneca, Charnwood

AstraZeneca has thrown more light on the pending closure of its UK R&D site in Charnwood, saying that 90% of …

News

First stem cell trial halted due to costs

November 18, 2011
Research and Development Geron, Stem cells

One of the world’s first stem cell trials has been put on hold due to ‘uncertain economic conditions’.Geron, the firm undertaking …

News

Bayer forecasts €11 billion growth in Asia

November 17, 2011
Bayer, China, emerging markets

Bayer is expecting sales in Asia to grow by €11 billion over the next four years, with over half of …

News

Industry supports bid to revitalise antibiotic research

November 17, 2011
Research and Development, Sales and Marketing EFPIA, Europe, IMI, antibiotic

The European Commission and the European pharma industry have unveiled plans to accelerate the discovery and development of new antibiotics. …

News

Jeremy Poland

November 17, 2011
Sales and Marketing MSI Consultancy

Pharmaceutical consultancy firm The MSI Consultancy has appointed Jeremy Poland as a Graduate Analyst in its Marketing Sciences division. Jeremy …

Appointment

NICE will not back Eisai’s Halaven

November 17, 2011
Medical Communications, Sales and Marketing Eisai, Halaven, NICE, breast cancer

NICE has not recommended Eisai’s novel breast cancer drug Halaven due to concerns over its safety and cost.In draft guidance …

News
life_healthcare_jpg

Life Healthcare makes four new appointments

November 16, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life healthcare communications

Life Healthcare Communications has made four new appointments, adding to its client service, creative and digital teams. Vicki Marsh joins …

Appointment

GSK diabetes drug fails head-to-head against Victoza

November 16, 2011
Sales and Marketing GLP-1, Victoza, albiglutide, diabetes

GlaxoSmithKline’s long-acting diabetes drug albiglutide has failed in a head-to-head trial against Novo Nordisk’s Victoza. Albiglutide is an injectable glucagon-like …

News

Multaq raises risk of death in permanent AF patients

November 16, 2011
Sales and Marketing AF, Multaq, Sanofi

More bad news for Sanofi’s Multaq as new data shows the drug doubles the risk of death in people with …

News

Is global consistency in GCP interpretation an achievable goal?

November 16, 2011
Research and Development

The potential benefits of standardisation in the conduct of an increasingly global clinical research effort are enormous. The promise of …

Feature
Thought Leadership

Quicker and slicker: new initiatives to improve clinical trial delivery

November 16, 2011
Research and Development

Faster study set-up times, reduced bureaucracy and timely patient recruitment – these things are central to the success of commercial …

Feature
Thought Leadership
The Gateway to Local Adoption Series

Latest content

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026